Studying the coagulopathy of COVID-19.

Spyropoulos, Alex C; Bonaca, Marc P

Spyropoulos, Alex C; Bonaca, Marc P.

Spyropoulos AC; The Institute for Health System Science, The Feinstein Institutes for Medical Research, and The Donald and Barbara Zucker School of Medicine at Hofstra and Northwell, and Department of Medicine, Anti-Coagulation and Clinical Thrombosis Services, Northwell Health at Lenox Hill Hospital, New York 10075, NY, USA; Department of Obstetrics and Gynecology, I M Sechenov First Moscow State Medical University, Moscow, Russia. Electronic address: aspyropoul@northwell.edu.
Bonaca MP; Division of Cardiology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA; CPC Clinical Research, Aurora, CO, USA.

Lancet ; 399(10320): 118-119, 2022 01 08.

Article in English | MEDLINE | ID: covidwho-1612113

Subject(s)

Blood Coagulation Disorders; COVID-19; Blood Coagulation; Blood Coagulation Disorders/etiology; Humans; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Blood Coagulation Disorders / COVID-19 Limits: Humans Language: English Journal: Lancet Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google